Denied

No. 20-1232

IBSA Institut Biochimique, S. A., et al. v. Teva Pharmaceuticals USA, Inc.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Petition DENIED.

DISTRIBUTED for Conference of 4/1/2021.

Waiver of right of respondent Teva Pharmaceuticals USA, Inc. to respond filed.

Petition for a writ of certiorari filed. (Response due April 7, 2021)

Parties

IBSA Institut Biochimique, S.A, et al., Petitioner, represented by Jeffrey J. Oelke

IBSA Institut Biochimique, S. A., et al., Altergon, S.A., IBSA Pharma Inc., Petitioners, Petitioner, represented by Erica Ruth Sutter

IBSA Istitut Biochimique, S.A., et al., Altergon, S.A., IBSA Pharma Inc., Petitioners, Petitioner, represented by Laura Theresa Moran

Teva Pharmaceuticals USA, Inc., Respondent, represented by John Christopher Rozendaal

 
Last updated: August 4, 2021